Newsroom

Sorted by: Latest
-

MREO Investor Alert - Mereo BioPharma Group plc Investors with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Mereo BioPharma Group plc. (NASDAQ: MREO) American Depository Shares ("ADS") between June 5, 2023 and December 26, 2025. Mereo is a biopharmaceutical company focused on the development of therapeutics for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the alleg...
-

HTGC Investors Have Opportunity to Lead Hercules Capital, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--HTGC Investors Have Opportunity to Lead Hercules Capital, Inc. Securities Fraud Lawsuit with the Schall Law Firm...
-

Oceaneering Schedules First Quarter 2026 Earnings Release and Conference Call

HOUSTON--(BUSINESS WIRE)--Oceaneering Schedules First Quarter 2026 Earnings Release and Conference Call: April 22 and April 23, respectively....
-

Pembina Pipeline Declares Quarterly Preferred Share Dividends and Announces Business Update and First Quarter 2026 Results Conference Calls

CALGARY, Alberta--(BUSINESS WIRE)--Pembina Pipeline Corporation ("Pembina" or the "Company") (TSX: PPL; NYSE: PBA) announced today that its Board of Directors has declared quarterly dividends for the Company's preferred shares, Series 1, 3, 5, 7, 15, 17, 21 and 25. Series 1, 3, 5, 7, and 21 preferred share dividends are payable on June 1, 2026, to shareholders of record on May 1, 2026. Series 15 and 17 preferred share dividends are payable on June 30, 2026, to shareholders of record on June 15,...
-

Poxel Confirms the Drawdown Under the Additional Tranche D PDR Bond Issue as Part of the Continuation Plan

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical-stage biopharmaceutical company that has developed innovative treatments for serious chronic diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic diseases (the "Company"), announces that it has signed, on March 25, 2026, the new Tranche D PDR subscription agreement with IPF Partners ("IPF"), for €3.75 million as part of th...
-

Poxel confirme la mise à disposition de l’emprunt obligataire complémentaire Tranche D PDR dans le cadre du plan de continuation

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), une entreprise biopharmaceutique en phase clinique qui a développé des traitements innovants pour des maladies chroniques graves à pathophysiologie métabolique, notamment la stéatohépatite associée au dysfonctionnement métabolique (MASH) et les maladies métaboliques rares (la « Société »), annonce avoir signé le 25 mars 2026 le nouvel accord de souscription Tranche D PDR avec IPF Partners (« IPF »), pour...
-

Riassunto: ECU Worldwide presenta l'espansione di XLERATE 2.0 per evitare le interruzioni nella catena di fornitura tra Europa e Asia

BRUXELLES--(BUSINESS WIRE)--ECU Worldwide, l'azienda globale interamente controllata di Allcargo Globals, ha annunciato un'espansione strategica della sua soluzione logistica innovativa, XLERATE 2.0, per fornire un'alternativa rapida e resiliente alle rotte commerciali tra Europa e Asia, che stanno subendo interruzioni nel transito. Questo percorso alternativo prevede il trasporto di merci attraverso l'Oceano Pacifico alla West Coast statunitense, utilizzando Los Angeles (LAX) come polo tempora...
-

ECU Worldwide verkündet Expansion von XLERATE 2.0 zur Umgehung der Unterbrechungen in der Lieferkette zwischen Asien und Europa

BRÜSSEL--(BUSINESS WIRE)--ECU Worldwide, die hundertprozentige Tochtergesellschaft von Allcargo Global, hat eine strategische Expansion ihrer transformativen Logistiklösung XLERATE 2.0 angekündigt, um eine schnelle und resiliente Alternative zu den unterbrochenen Handelswegen zwischen Asien und Europa bereitzustellen. Im Rahmen dieser alternativen Strecke werden Ladungen über den Pazifik zur Westküste der USA transportiert, wobei Los Angeles (LAX) als vorübergehende Drehscheibe dient. Die Lösun...
-

Samenvatting: ECU Worldwide introduceert XLERATE 2.0 om verstoringen in toeleveringsketen van Azië naar Europa te omzeilen

BRUSSEL--(BUSINESS WIRE)--ECU Worldwide, de volledige dochteronderneming van Allcargo Globals, heeft een strategische uitbreiding aangekondigd van XLERATE 2.0, haar baanbrekende logistieke oplossing. Hiermee wil het een snel en veerkrachtig alternatief bieden voor de handelsroutes tussen Azië en Europa, en de verstoringen in het transport wegnemen. Met deze alternatieve route wordt de lading over de Stille Oceaan naar de westkust van de VS vervoerd, en fungeert Los Angeles (LAX) als tijdelijke...
-

ECU Worldwide inaugure l'élargissement de XLERATE 2.0 afin de contourner les perturbations de la chaîne d'approvisionnement Asie-Europe

BRUXELLES--(BUSINESS WIRE)--ECU Worldwide, filiale mondiale détenue à 100 % par Allcargo Global, a annoncé une expansion stratégique de sa solution logistique transformatrice, XLERATE 2.0, afin de fournir une alternative rapide et résiliente aux voies commerciales Asie-Europe confrontées à des perturbations de transit. Dans le cadre de cet itinéraire alternatif, les marchandises traversent le Pacifique jusqu'à la côte ouest américaine et utilisent Los Angeles (LAX) comme hub de transit temporai...